Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

AI-Assisted Structured Guidance for Narrative Review Writing

25 mai 2026 mis à jour par: Zhongshan Ophthalmic Center, Sun Yat-sen University

Effect of Artificial Intelligence-Assisted Structured Guidance on the Quality of Narrative Literature Reviews Among Medical Postgraduate Students: A Randomized Controlled Educational Study

This randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students. A total of 102 students enrolled in an academic writing course will be randomly assigned to either an AI-assisted structured guidance group or a free AI use group. Both groups may use AI tools under academic integrity requirements and will complete a narrative literature review according to the same course requirements. The guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six dimensions of the Scale for the Assessment of Narrative Review Articles (SANRA). The primary outcome is the final SANRA total score of the submitted narrative literature review.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Intervention / Traitement

Description détaillée

Generative artificial intelligence is increasingly used by medical students and postgraduate trainees for literature searching, summarization, outlining, and academic writing. However, free use of AI may be associated with inaccurate information, unsupported statements, fabricated references, and inadequate academic judgment. This study is designed to evaluate whether structured guidance can improve the quality and academic integrity of AI-assisted narrative review writing.

Participants will be medical postgraduate students enrolled in an academic writing course. After informed consent and baseline data collection, participants will be randomized in a 1:1 ratio to an AI-assisted structured guidance group or a free AI use group. Both groups will complete a narrative literature review of approximately 2,000 Chinese characters according to the same course requirements and may use AI tools under academic integrity requirements.

Participants in the AI-assisted structured guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six SANRA dimensions: explanation of the importance of the article, statement of aims or questions, description of the literature search, reference support for key statements, scientific reasoning, and appropriate presentation of data and content. The instructor will provide directional and methodological feedback but will not directly write or edit the students' text line by line. Participants in the free AI use group will complete the review according to the same course requirements without the structured guidance session.

After submission, all narrative reviews will be anonymized and assessed by independent outcome assessors blinded to group allocation. The primary outcome is the final SANRA total score. Secondary outcomes include SANRA item scores, multiple-source academic writing self-efficacy, and reference authenticity error rate.

Type d'étude

Interventionnel

Inscription (Estimé)

102

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

  • Chine
    • Guangdong
      • Guangzhou, Guangdong, Chine, 510060
        • Zhongshan Ophthalmic Center, Sun Yat-sen University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  1. Master's students enrolled in the Academic Standards and Thesis Writing course.
  2. Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
  3. Able to complete literature searching, use AI tools, and complete online questionnaires.

Exclusion Criteria:

  1. Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
  2. Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: AI-Assisted Structured Guidance Group
Participants in this group will complete a narrative literature review according to the same course requirements as the control group. They may use AI tools under academic integrity requirements and will additionally receive one structured guidance session approximately two weeks before final submission.
Comportemental: AI-Assisted Structured Guidance
A single structured guidance session delivered approximately two weeks before final submission. The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Comportemental: Free AI Use
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review. Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
Comparateur actif: Free AI Use Group
Participants in this group will complete a narrative literature review according to the same course requirements and may use AI tools under academic integrity requirements. They will not receive the structured guidance session during the study period.
Comportemental: Free AI Use
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review. Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Final SANRA Total Score
Délai: Week 2
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA). The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
SANRA Item 1 Score: Importance of the Article
Délai: Week 2
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 2 Score: Aims or Questions
Délai: Week 2
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 3 Score: Literature Search Description
Délai: Week 2
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 4 Score: Referencing
Délai: Week 2
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 5 Score: Scientific Reasoning
Délai: Week 2
This outcome assesses SANRA item 5, which evaluates whether the scientific reasoning is based on appropriate evidence. The item score ranges from 0 to 2, with higher scores indicating better scientific reasoning.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 6 Score: Data and Content Presentation
Délai: Week 2
This outcome assesses SANRA item 6, which evaluates whether data and content are presented appropriately. The item score ranges from 0 to 2, with higher scores indicating better presentation.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
Change From Baseline in Multiple-Source Academic Writing Self-Efficacy Score
Délai: Baseline and Week 2
Multiple-source academic writing self-efficacy will be assessed using an adapted 8-item Multiple-Source Academic Writing Self-Efficacy Scale. The change from baseline to final submission will be analyzed. Higher scores indicate greater self-efficacy in integrating multiple sources for academic writing.
Baseline and Week 2
Reference Authenticity Error Rate
Délai: Week 2
The proportion of references with authenticity errors will be calculated for each submitted narrative literature review. References will be verified using available bibliographic information such as DOI, PMID, title, authors, PubMed, CrossRef, Web of Science, Google Scholar, journal websites, or publisher websites. A higher error rate indicates poorer reference authenticity.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Zhongshan Ophthalmic Center, Sun Yat-sen University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 juin 2026

Achèvement primaire (Estimé)

1 août 2026

Achèvement de l'étude (Estimé)

1 septembre 2026

Dates d'inscription aux études

Première soumission

25 mai 2026

Première soumission répondant aux critères de contrôle qualité

25 mai 2026

Première publication (Réel)

1 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

1 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

25 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Mots clés

Autres numéros d'identification d'étude

  • IIT2026064

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared because the study involves students' coursework, questionnaires, AI use declarations, and writing-related educational data. These data may contain potentially identifiable information even after de-identification. Only aggregated results will be reported in publications or academic presentations.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner